Genetic study of Alzheimer's dementia in Korean seniors
Part of Brain & nervous system, Mental health clinical trials.
This study looks at genes that may be linked to Alzheimer's dementia. It compares older adults with and without dementia to understand why some people develop it. If you or a loved one is over 60 and has been diagnosed with Alzheimer's dementia, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 60 years old or older.
- You must either have a diagnosis of Alzheimer's dementia or be a healthy older adult without dementia.
- If you have dementia, your memory test score must be below 24 and your dementia rating must be above 0.5.
- If you are healthy, your memory test score must be 24 or higher and your dementia rating must be 0.
- You cannot have serious health problems like unstable heart, lung, or kidney disease.
- You must be able to give consent or have a guardian with you if your memory is very poor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies genes to better understand why some people develop dementia and memory problems earlier in life. It may help researchers find clearer causes and improve future testing and treatments for families affected by dementia.
This study supports Alzheimer’s research by collecting health and thinking (cognitive) test results and blood samples to study genetics and biomarkers. You may be enrolled if you’re age 40 or older and can do these checkups, even if you have mild memory problems or dementia.
This study looks at people from families with inherited Alzheimer’s disease, including those who may be cognitively normal. It uses medical checkups and brain/nerve tests to better understand Alzheimer’s risk and symptoms in families with specific gene changes.
This study follows people who are at risk for a specific inherited form of Alzheimer’s disease (because a parent has it). It helps researchers learn how the disease starts and changes over time, especially in people who still feel cognitively normal.
This study collects biological samples (blood or cells) from families where two or more members have been diagnosed with Alzheimer's disease or dementia. Researchers use these samples to identify genetic factors that may cause or increase risk for these conditions.
This study looks for brain/biological “signals” (biomarkers) that may identify Alzheimer’s disease earlier, including stages before clear symptoms. You may be followed for about 5 years, with repeated memory and thinking testing to see how these signs relate to future diagnosis.
Hear when a new Alzheimer Dementia (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.